Skip to main content
. 2021 Jul 28;19:224. doi: 10.1186/s12951-021-00966-6

Fig. 5.

Fig. 5

Cur@α-NTP-LNs inhibited 5-8F subcutaneous tumor growth. a Schematic diagram of Cur@α-NTP-LNs treatment on 5-8F subcutaneous tumors. b Tumor volume in each group over time. The tumor volume in the Cur@α-NTP-LNs-treated group was significantly smaller than that in other groups (n = 5). c Evaluation of the side effects of Cur@α-NTP-LNs, α-NTP-LNs, free Cur or PBS in vivo. (n ≥ 3). Results are presented as mean ± s.d. ***p < 0.001